APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prilide Antihypertensive Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Prilide Antihypertensive Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025198 pages

Choose your research edition.

Industry ResearchPrilide Antihypertensive Drugs Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Prilide Antihypertensive Drugs Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Prilide Antihypertensive Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prilide Antihypertensive Drugs Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Prilide Antihypertensive Drugs Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Prilide Antihypertensive Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Prilide Antihypertensive Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prilide Antihypertensive Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prilide Antihypertensive Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Prilide Antihypertensive Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Prilide Antihypertensive Drugs include Zhongfu Pharmaceutical, Huahai Pharmaceutical, Changjiang Pharmaceutical, Abbott, Sanofi, Humanwell Pharmaceutical, Poly Pharm, Novartis and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Prilide Antihypertensive Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prilide Antihypertensive Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prilide Antihypertensive Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prilide Antihypertensive Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Prilide Antihypertensive Drugs Segment by Company

Zhongfu Pharmaceutical

Huahai Pharmaceutical

Changjiang Pharmaceutical

Abbott

Sanofi

Humanwell Pharmaceutical

Poly Pharm

Novartis

Merck

Lukang Group

Likang Pharmaceutical

Pfizer

Hengwei Pharmaceutical

Hengcheng Pharmaceutical

Changzhou Pharmaceutical

Baili Pharmaceutical

Baiyunshan Pharmaceutical

Prilide Antihypertensive Drugs Segment by Type

Enalapril

Lisinopril

Captopril

Fosinopril

Others

Prilide Antihypertensive Drugs Segment by Application

Hospital

Clinic

Prilide Antihypertensive Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prilide Antihypertensive Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prilide Antihypertensive Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prilide Antihypertensive Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Prilide Antihypertensive Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prilide Antihypertensive Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Prilide Antihypertensive Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Prilide Antihypertensive Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Prilide Antihypertensive Drugs Industry Trends Table 2. Prilide Antihypertensive Drugs Industry Drivers Table 3. Prilide Antihypertensive Drugs Industry Opportunities and Challenges Table 4. Prilide Antihypertensive Drugs Industry Restraints Table 5. Global Prilide Antihypertensive Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Prilide Antihypertensive Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Prilide Antihypertensive Drugs Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Prilide Antihypertensive Drugs Sales Market Share by Manufacturers Table 9. Global Prilide Antihypertensive Drugs Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Prilide Antihypertensive Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Prilide Antihypertensive Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Prilide Antihypertensive Drugs Manufacturers, Product Type & Application Table 13. Global Prilide Antihypertensive Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Prilide Antihypertensive Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Enalapril Table 17. Major Manufacturers of Lisinopril Table 18. Major Manufacturers of Captopril Table 19. Major Manufacturers of Fosinopril Table 20. Major Manufacturers of Others Table 21. Global Prilide Antihypertensive Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Prilide Antihypertensive Drugs Sales by Type (2021-2026) & (k units) Table 23. Global Prilide Antihypertensive Drugs Sales by Type (2027-2032) & (k units) Table 24. Global Prilide Antihypertensive Drugs Sales Market Share by Type (2021-2026) Table 25. Global Prilide Antihypertensive Drugs Sales Market Share by Type (2027-2032) Table 26. Global Prilide Antihypertensive Drugs Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Prilide Antihypertensive Drugs Revenue by Type (2021-2026) & (k units) Table 28. Global Prilide Antihypertensive Drugs Revenue by Type (2027-2032) & (k units) Table 29. Global Prilide Antihypertensive Drugs Revenue Market Share by Type (2021-2026) Table 30. Global Prilide Antihypertensive Drugs Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Clinic Table 33. Global Prilide Antihypertensive Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Prilide Antihypertensive Drugs Sales by Application (2021-2026) & (k units) Table 35. Global Prilide Antihypertensive Drugs Sales by Application (2027-2032) & (k units) Table 36. Global Prilide Antihypertensive Drugs Sales Market Share by Application (2021-2026) Table 37. Global Prilide Antihypertensive Drugs Sales Market Share by Application (2027-2032) Table 38. Global Prilide Antihypertensive Drugs Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Prilide Antihypertensive Drugs Revenue by Application (2021-2026) & (k units) Table 40. Global Prilide Antihypertensive Drugs Revenue by Application (2027-2032) & (k units) Table 41. Global Prilide Antihypertensive Drugs Revenue Market Share by Application (2021-2026) Table 42. Global Prilide Antihypertensive Drugs Revenue Market Share by Application (2027-2032) Table 43. Global Prilide Antihypertensive Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Prilide Antihypertensive Drugs Sales by Region (2021-2026) & (k units) Table 45. Global Prilide Antihypertensive Drugs Sales Market Share by Region (2021-2026) Table 46. Global Prilide Antihypertensive Drugs Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Prilide Antihypertensive Drugs Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Prilide Antihypertensive Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Prilide Antihypertensive Drugs Sales by Country (2021-2026) & (k units) Table 50. North America Prilide Antihypertensive Drugs Sales by Country (2027-2032) & (k units) Table 51. Europe Prilide Antihypertensive Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Prilide Antihypertensive Drugs Sales by Country (2021-2026) & (k units) Table 53. Europe Prilide Antihypertensive Drugs Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Prilide Antihypertensive Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Prilide Antihypertensive Drugs Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Prilide Antihypertensive Drugs Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Prilide Antihypertensive Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Prilide Antihypertensive Drugs Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Prilide Antihypertensive Drugs Sales by Country (2027-2032) & (k units) Table 60. Global Prilide Antihypertensive Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Prilide Antihypertensive Drugs Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Prilide Antihypertensive Drugs Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Prilide Antihypertensive Drugs Revenue Market Share by Region (2021-2026) Table 64. Global Prilide Antihypertensive Drugs Revenue Market Share by Region (2027-2032) Table 65. Zhongfu Pharmaceutical Company Information Table 66. Zhongfu Pharmaceutical Business Overview Table 67. Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 69. Zhongfu Pharmaceutical Recent Development Table 70. Huahai Pharmaceutical Company Information Table 71. Huahai Pharmaceutical Business Overview Table 72. Huahai Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Huahai Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 74. Huahai Pharmaceutical Recent Development Table 75. Changjiang Pharmaceutical Company Information Table 76. Changjiang Pharmaceutical Business Overview Table 77. Changjiang Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Changjiang Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 79. Changjiang Pharmaceutical Recent Development Table 80. Abbott Company Information Table 81. Abbott Business Overview Table 82. Abbott Prilide Antihypertensive Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Abbott Prilide Antihypertensive Drugs Product Portfolio Table 84. Abbott Recent Development Table 85. Sanofi Company Information Table 86. Sanofi Business Overview Table 87. Sanofi Prilide Antihypertensive Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Sanofi Prilide Antihypertensive Drugs Product Portfolio Table 89. Sanofi Recent Development Table 90. Humanwell Pharmaceutical Company Information Table 91. Humanwell Pharmaceutical Business Overview Table 92. Humanwell Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Humanwell Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 94. Humanwell Pharmaceutical Recent Development Table 95. Poly Pharm Company Information Table 96. Poly Pharm Business Overview Table 97. Poly Pharm Prilide Antihypertensive Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Poly Pharm Prilide Antihypertensive Drugs Product Portfolio Table 99. Poly Pharm Recent Development Table 100. Novartis Company Information Table 101. Novartis Business Overview Table 102. Novartis Prilide Antihypertensive Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Novartis Prilide Antihypertensive Drugs Product Portfolio Table 104. Novartis Recent Development Table 105. Merck Company Information Table 106. Merck Business Overview Table 107. Merck Prilide Antihypertensive Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Merck Prilide Antihypertensive Drugs Product Portfolio Table 109. Merck Recent Development Table 110. Lukang Group Company Information Table 111. Lukang Group Business Overview Table 112. Lukang Group Prilide Antihypertensive Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Lukang Group Prilide Antihypertensive Drugs Product Portfolio Table 114. Lukang Group Recent Development Table 115. Likang Pharmaceutical Company Information Table 116. Likang Pharmaceutical Business Overview Table 117. Likang Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Likang Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 119. Likang Pharmaceutical Recent Development Table 120. Pfizer Company Information Table 121. Pfizer Business Overview Table 122. Pfizer Prilide Antihypertensive Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Pfizer Prilide Antihypertensive Drugs Product Portfolio Table 124. Pfizer Recent Development Table 125. Hengwei Pharmaceutical Company Information Table 126. Hengwei Pharmaceutical Business Overview Table 127. Hengwei Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Hengwei Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 129. Hengwei Pharmaceutical Recent Development Table 130. Hengcheng Pharmaceutical Company Information Table 131. Hengcheng Pharmaceutical Business Overview Table 132. Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 134. Hengcheng Pharmaceutical Recent Development Table 135. Changzhou Pharmaceutical Company Information Table 136. Changzhou Pharmaceutical Business Overview Table 137. Changzhou Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Changzhou Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 139. Changzhou Pharmaceutical Recent Development Table 140. Baili Pharmaceutical Company Information Table 141. Baili Pharmaceutical Business Overview Table 142. Baili Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Baili Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 144. Baili Pharmaceutical Recent Development Table 145. Baiyunshan Pharmaceutical Company Information Table 146. Baiyunshan Pharmaceutical Business Overview Table 147. Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 149. Baiyunshan Pharmaceutical Recent Development Table 150. Key Raw Materials Table 151. Raw Materials Key Suppliers Table 152. Prilide Antihypertensive Drugs Distributors List Table 153. Prilide Antihypertensive Drugs Customers List Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Prilide Antihypertensive Drugs Product Image Figure 2. Global Prilide Antihypertensive Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prilide Antihypertensive Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Prilide Antihypertensive Drugs Sales (2021-2032) & (k units) Figure 5. Global Prilide Antihypertensive Drugs Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Prilide Antihypertensive Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Enalapril Image Figure 9. Lisinopril Image Figure 10. Captopril Image Figure 11. Fosinopril Image Figure 12. Others Image Figure 13. Global Prilide Antihypertensive Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Prilide Antihypertensive Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Prilide Antihypertensive Drugs Sales Market Share by Type (2021-2032) Figure 16. Global Prilide Antihypertensive Drugs Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Prilide Antihypertensive Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Prilide Antihypertensive Drugs Revenue Market Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Global Prilide Antihypertensive Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Prilide Antihypertensive Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Prilide Antihypertensive Drugs Sales Market Share by Application (2021-2032) Figure 24. Global Prilide Antihypertensive Drugs Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Prilide Antihypertensive Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Prilide Antihypertensive Drugs Revenue Market Share by Application (2021-2032) Figure 27. North America Prilide Antihypertensive Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Prilide Antihypertensive Drugs Sales Market Share by Country (2021-2032) Figure 29. U.S. Prilide Antihypertensive Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Prilide Antihypertensive Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Prilide Antihypertensive Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Prilide Antihypertensive Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Prilide Antihypertensive Drugs Sales Market Share by Country (2021-2032) Figure 34. Germany Prilide Antihypertensive Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Prilide Antihypertensive Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Prilide Antihypertensive Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Prilide Antihypertensive Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Prilide Antihypertensive Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Prilide Antihypertensive Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Prilide Antihypertensive Drugs Sales Market Share by Country (2021-2032) Figure 41. China Prilide Antihypertensive Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Prilide Antihypertensive Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Prilide Antihypertensive Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Prilide Antihypertensive Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Prilide Antihypertensive Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Prilide Antihypertensive Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Prilide Antihypertensive Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Prilide Antihypertensive Drugs Sales Market Share by Country (2021-2032) Figure 49. Brazil Prilide Antihypertensive Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Prilide Antihypertensive Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Prilide Antihypertensive Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Prilide Antihypertensive Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Prilide Antihypertensive Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Prilide Antihypertensive Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Prilide Antihypertensive Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Prilide Antihypertensive Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Prilide Antihypertensive Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Prilide Antihypertensive Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Figure 60. North America Prilide Antihypertensive Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Figure 62. Europe Prilide Antihypertensive Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Prilide Antihypertensive Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Prilide Antihypertensive Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Prilide Antihypertensive Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Prilide Antihypertensive Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Enalapril
  • Lisinopril
  • Captopril
  • Fosinopril
  • Others
Applications
  • Hospital
  • Clinic
Companies covered
  • Zhongfu Pharmaceutical
  • Huahai Pharmaceutical
  • Changjiang Pharmaceutical
  • Abbott
  • Sanofi
  • Humanwell Pharmaceutical
  • Poly Pharm
  • Novartis
  • Merck
  • Lukang Group
  • Likang Pharmaceutical
  • Pfizer
  • Hengwei Pharmaceutical
  • Hengcheng Pharmaceutical
  • Changzhou Pharmaceutical
  • Baili Pharmaceutical
  • Baiyunshan Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Prilide Antihypertensive Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Prilide Antihypertensive Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Prilide Antihypertensive Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Prilide Antihypertensive Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Prilide Antihypertensive Drugs Market Dynamics
  1. 2.1 Prilide Antihypertensive Drugs Industry Trends
  2. 2.2 Prilide Antihypertensive Drugs Industry Drivers
  3. 2.3 Prilide Antihypertensive Drugs Industry Opportunities and Challenges
  4. 2.4 Prilide Antihypertensive Drugs Industry Restraints
3 Prilide Antihypertensive Drugs Market by Manufacturers
  1. 3.1 Global Prilide Antihypertensive Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Prilide Antihypertensive Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Prilide Antihypertensive Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Prilide Antihypertensive Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Prilide Antihypertensive Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Prilide Antihypertensive Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Prilide Antihypertensive Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Prilide Antihypertensive Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Prilide Antihypertensive Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Prilide Antihypertensive Drugs Tier 1, Tier 2, and Tier 3
4 Prilide Antihypertensive Drugs Market by Type
  1. 4.1 Prilide Antihypertensive Drugs Type Introduction
  2. 4.1.1 Enalapril
  3. 4.1.2 Lisinopril
  4. 4.1.3 Captopril
  5. 4.1.4 Fosinopril
  6. 4.1.5 Others
  7. 4.2 Global Prilide Antihypertensive Drugs Sales by Type
  8. 4.2.1 Global Prilide Antihypertensive Drugs Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Prilide Antihypertensive Drugs Sales by Type (2021-2032)
  10. 4.2.3 Global Prilide Antihypertensive Drugs Sales Market Share by Type (2021-2032)
  11. 4.3 Global Prilide Antihypertensive Drugs Revenue by Type
  12. 4.3.1 Global Prilide Antihypertensive Drugs Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Prilide Antihypertensive Drugs Revenue by Type (2021-2032)
  14. 4.3.3 Global Prilide Antihypertensive Drugs Revenue Market Share by Type (2021-2032)
5 Prilide Antihypertensive Drugs Market by Application
  1. 5.1 Prilide Antihypertensive Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Prilide Antihypertensive Drugs Sales by Application
  5. 5.2.1 Global Prilide Antihypertensive Drugs Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Prilide Antihypertensive Drugs Sales by Application (2021-2032)
  7. 5.2.3 Global Prilide Antihypertensive Drugs Sales Market Share by Application (2021-2032)
  8. 5.3 Global Prilide Antihypertensive Drugs Revenue by Application
  9. 5.3.1 Global Prilide Antihypertensive Drugs Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Prilide Antihypertensive Drugs Revenue by Application (2021-2032)
  11. 5.3.3 Global Prilide Antihypertensive Drugs Revenue Market Share by Application (2021-2032)
6 Global Prilide Antihypertensive Drugs Sales by Region
  1. 6.1 Global Prilide Antihypertensive Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prilide Antihypertensive Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Prilide Antihypertensive Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Prilide Antihypertensive Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Prilide Antihypertensive Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Prilide Antihypertensive Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Prilide Antihypertensive Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Prilide Antihypertensive Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Prilide Antihypertensive Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Prilide Antihypertensive Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Prilide Antihypertensive Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Prilide Antihypertensive Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Prilide Antihypertensive Drugs Revenue by Region
  1. 7.1 Global Prilide Antihypertensive Drugs Revenue by Region
  2. 7.1.1 Global Prilide Antihypertensive Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Prilide Antihypertensive Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Prilide Antihypertensive Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Prilide Antihypertensive Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Prilide Antihypertensive Drugs Revenue (2021-2032)
  8. 7.2.2 North America Prilide Antihypertensive Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Prilide Antihypertensive Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Prilide Antihypertensive Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Prilide Antihypertensive Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Prilide Antihypertensive Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Prilide Antihypertensive Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Prilide Antihypertensive Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhongfu Pharmaceutical
  2. 8.1.1 Zhongfu Pharmaceutical Company Information
  3. 8.1.2 Zhongfu Pharmaceutical Business Overview
  4. 8.1.3 Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  6. 8.1.5 Zhongfu Pharmaceutical Recent Developments
  7. 8.2 Huahai Pharmaceutical
  8. 8.2.1 Huahai Pharmaceutical Company Information
  9. 8.2.2 Huahai Pharmaceutical Business Overview
  10. 8.2.3 Huahai Pharmaceutical Prilide Antihypertensive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Huahai Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  12. 8.2.5 Huahai Pharmaceutical Recent Developments
  13. 8.3 Changjiang Pharmaceutical
  14. 8.3.1 Changjiang Pharmaceutical Company Information
  15. 8.3.2 Changjiang Pharmaceutical Business Overview
  16. 8.3.3 Changjiang Pharmaceutical Prilide Antihypertensive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Changjiang Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  18. 8.3.5 Changjiang Pharmaceutical Recent Developments
  19. 8.4 Abbott
  20. 8.4.1 Abbott Company Information
  21. 8.4.2 Abbott Business Overview
  22. 8.4.3 Abbott Prilide Antihypertensive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Abbott Prilide Antihypertensive Drugs Product Portfolio
  24. 8.4.5 Abbott Recent Developments
  25. 8.5 Sanofi
  26. 8.5.1 Sanofi Company Information
  27. 8.5.2 Sanofi Business Overview
  28. 8.5.3 Sanofi Prilide Antihypertensive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi Prilide Antihypertensive Drugs Product Portfolio
  30. 8.5.5 Sanofi Recent Developments
  31. 8.6 Humanwell Pharmaceutical
  32. 8.6.1 Humanwell Pharmaceutical Company Information
  33. 8.6.2 Humanwell Pharmaceutical Business Overview
  34. 8.6.3 Humanwell Pharmaceutical Prilide Antihypertensive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Humanwell Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  36. 8.6.5 Humanwell Pharmaceutical Recent Developments
  37. 8.7 Poly Pharm
  38. 8.7.1 Poly Pharm Company Information
  39. 8.7.2 Poly Pharm Business Overview
  40. 8.7.3 Poly Pharm Prilide Antihypertensive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Poly Pharm Prilide Antihypertensive Drugs Product Portfolio
  42. 8.7.5 Poly Pharm Recent Developments
  43. 8.8 Novartis
  44. 8.8.1 Novartis Company Information
  45. 8.8.2 Novartis Business Overview
  46. 8.8.3 Novartis Prilide Antihypertensive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Novartis Prilide Antihypertensive Drugs Product Portfolio
  48. 8.8.5 Novartis Recent Developments
  49. 8.9 Merck
  50. 8.9.1 Merck Company Information
  51. 8.9.2 Merck Business Overview
  52. 8.9.3 Merck Prilide Antihypertensive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Merck Prilide Antihypertensive Drugs Product Portfolio
  54. 8.9.5 Merck Recent Developments
  55. 8.10 Lukang Group
  56. 8.10.1 Lukang Group Company Information
  57. 8.10.2 Lukang Group Business Overview
  58. 8.10.3 Lukang Group Prilide Antihypertensive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Lukang Group Prilide Antihypertensive Drugs Product Portfolio
  60. 8.10.5 Lukang Group Recent Developments
  61. 8.11 Likang Pharmaceutical
  62. 8.11.1 Likang Pharmaceutical Company Information
  63. 8.11.2 Likang Pharmaceutical Business Overview
  64. 8.11.3 Likang Pharmaceutical Prilide Antihypertensive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Likang Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  66. 8.11.5 Likang Pharmaceutical Recent Developments
  67. 8.12 Pfizer
  68. 8.12.1 Pfizer Company Information
  69. 8.12.2 Pfizer Business Overview
  70. 8.12.3 Pfizer Prilide Antihypertensive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Pfizer Prilide Antihypertensive Drugs Product Portfolio
  72. 8.12.5 Pfizer Recent Developments
  73. 8.13 Hengwei Pharmaceutical
  74. 8.13.1 Hengwei Pharmaceutical Company Information
  75. 8.13.2 Hengwei Pharmaceutical Business Overview
  76. 8.13.3 Hengwei Pharmaceutical Prilide Antihypertensive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hengwei Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  78. 8.13.5 Hengwei Pharmaceutical Recent Developments
  79. 8.14 Hengcheng Pharmaceutical
  80. 8.14.1 Hengcheng Pharmaceutical Company Information
  81. 8.14.2 Hengcheng Pharmaceutical Business Overview
  82. 8.14.3 Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  84. 8.14.5 Hengcheng Pharmaceutical Recent Developments
  85. 8.15 Changzhou Pharmaceutical
  86. 8.15.1 Changzhou Pharmaceutical Company Information
  87. 8.15.2 Changzhou Pharmaceutical Business Overview
  88. 8.15.3 Changzhou Pharmaceutical Prilide Antihypertensive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Changzhou Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  90. 8.15.5 Changzhou Pharmaceutical Recent Developments
  91. 8.16 Baili Pharmaceutical
  92. 8.16.1 Baili Pharmaceutical Company Information
  93. 8.16.2 Baili Pharmaceutical Business Overview
  94. 8.16.3 Baili Pharmaceutical Prilide Antihypertensive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Baili Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  96. 8.16.5 Baili Pharmaceutical Recent Developments
  97. 8.17 Baiyunshan Pharmaceutical
  98. 8.17.1 Baiyunshan Pharmaceutical Company Information
  99. 8.17.2 Baiyunshan Pharmaceutical Business Overview
  100. 8.17.3 Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  102. 8.17.5 Baiyunshan Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Prilide Antihypertensive Drugs Value Chain Analysis
  2. 9.1.1 Prilide Antihypertensive Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Prilide Antihypertensive Drugs Production Mode & Process
  6. 9.2 Prilide Antihypertensive Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Prilide Antihypertensive Drugs Distributors
  9. 9.2.3 Prilide Antihypertensive Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst